Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
HTLV-1関連脊髄症を治療することに用いるための医薬組成物
Document Type and Number:
Japanese Patent JP7125353
Kind Code:
B2
Abstract:
The present invention provides a pharmaceutical composition containing an inhibitor selected from the group consisting of an EZH1 inhibitor, an EZH2 inhibitor and an EZH1/2 dual inhibitor as an active ingredient, for use in treating HTLV-1-associated myelopathy. The present invention provides a pharmaceutical composition for use in treating HTLV-1-associated myelopathy, containing a 1,3-benzodioxole derivative or a pharmaceutically acceptable salt thereof.

Inventors:
Yoshihisa Yamano
Natsumi Ueda
Araki Kazushi
Application Number:
JP2018562415A
Publication Date:
August 24, 2022
Filing Date:
January 18, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Daiichi Sankyo Co., Ltd.
St. Marianna University School of Medicine
International Classes:
A61K31/496; A61K31/4412; A61K31/5377; A61P25/02; A61P31/14; C12N15/09
Foreign References:
WO2015141616A1
WO2011140324A1
WO2012142504A1
WO2011129424A1
Other References:
臨床検査, 2005, Vol.49, No.4, pp.409-414
医学のあゆみ, 2015, Vol.255, No.5, pp.485-490
Journal of Medicinal Chemistry, 2016, Vol.59, No.16, pp.7617-7633
Expert Opinion on Therapeutic Patents, 2017, Vol.27, No.7, pp.797-813
Attorney, Agent or Firm:
Seiji Ohno
Yuko Matsutoya
Shinsuke Umeda
Yu Morita
Chisuke Konno
Nobuto Oki